Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Share medical history to ensure safety
SeekPeptides members access curated information that reduces this research burden significantly
If starting with 50 mg titration (Weeks 12), subtract ~34 vials from totals below
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors it is not currently approved by the MHRA or EMA for routine clinical use in the UK
Ginsenoside Rc attenuates myocardial ischaemic injury through antioxidative and anti-inflammatory effects
In some embodiments, the otic formulation or composition comprises about 1% by weight of the silicon dioxide
US$ 29.23
US$ 29.12
US$ 21.88
US$ 29.74
US$ 28.91
